An Open Label International Multi-Center Phase 2 Activity And Safety Study Of SU011248 In Patients With Advanced / Metastatic Gastric Cancer Progressing Or Recurring After One Prior Chemotherapy.
Phase of Trial: Phase II
Latest Information Update: 03 Apr 2015
At a glance
- Drugs Sunitinib (Primary)
- Indications Gastric cancer
- Focus Therapeutic Use
- Sponsors Pfizer
- 17 Dec 2009 Patient numbers amended from 93 to 78 as reported by ClinicalTrials.gov.
- 10 Sep 2008 Actual patient number (93) added as reported by ClinicalTrials.gov.
- 10 Sep 2008 Actual end date (May 2008) added as reported by ClinicalTrials.gov.